Palle Valentiner-Branth

Statens Serum Institut - Infectious Disease Epidemiology & Prevention

SCHOLARLY PAPERS

8

DOWNLOADS
Rank 13,419

SSRN RANKINGS

Top 13,419

in Total Papers Downloads

6,925

SSRN CITATIONS

9

CROSSREF CITATIONS

1

Scholarly Papers (8)

1.

Risk of Reinfection, Vaccine Protection, and Severity of Infection with the BA.5 Omicron Subvariant: A Danish Nation-Wide Population-Based Study

Number of pages: 21 Posted: 18 Jul 2022
Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Statens Serum Institut - Department of Epidemiology Research, Statens Serum Institut - Department of Bacteria, Parasites and Fungi, Statens Serum Institut - Virus Research & Development Laboratory, Statens Serum Institut - Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Statens Serum Institut - Department of Epidemiology Research, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Statens Serum Institut, Statens Serum Institut and Statens Serum Institut - Infectious Disease Epidemiology & Prevention
Downloads 3,749 (5,677)
Citation 11

Abstract:

Loading...

Infectious diseases, covid-19, vaccine effectiveness, SARS-CoV-2, epidemiology, risk factors

2.

Reduced Risk of Hospitalisation Associated With Infection With SARS-CoV-2 Omicron Relative to Delta: A Danish Cohort Study

Number of pages: 27 Posted: 14 Jan 2022
Statens Serum Institut - Department of Epidemiology Research, Statens Serum Institut, Imperial College London - NIHR Health Protection Research Unit for Modelling and Health Economics, Statens Serum Institut, Statens Serum Institut, affiliation not provided to SSRN, Statens Serum Institut - Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Statens Serum Institut, Statens Serum Institut, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, affiliation not provided to SSRN, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, affiliation not provided to SSRN, Statens Serum Institut, affiliation not provided to SSRN, Statens Serum Institut - Department of Data Management and Analysis, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Copenhagen - Department of Public Health, University of Copenhagen - Department of Respiratory Medicine and Infectious Diseases, Statens Serum Institut - Department of Virus and Microbiological Special Diagnostics, Roskilde University - Department of Science and Environment, affiliation not provided to SSRN, Roskilde University - Department of Science and Environment, affiliation not provided to SSRN, affiliation not provided to SSRN, Aalborg University Hospital, University of Copenhagen - Hvidovre Hospital, University of Copenhagen - Copenhagen University Hospital, Aarhus University - Department of Infectious Diseases, Odense University Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Statens Serum Institut - Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut - Virus Research & Development Laboratory, Statens Serum Institut - Virus Research & Development Laboratory, Statens Serum Institut, Statens Serum Institut, affiliation not provided to SSRN, Statens Serum Institut, affiliation not provided to SSRN, Statens Serum Institut, affiliation not provided to SSRN and Statens Serum Institut
Downloads 1,466 (25,032)
Citation 7

Abstract:

Loading...

covid-19, SARS-CoV-2, virus, hospital admission, epidemiology

3.

Effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation: a nation-wide cohort study in Denmark, October 2023

Number of pages: 3 Posted: 22 Nov 2023
Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Statens Serum Institut - Virus Research & Development Laboratory, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Statens Serum Institut - Infectious Disease Epidemiology & Prevention and Statens Serum Institut
Downloads 635 (79,794)
Citation 1

Abstract:

Loading...

Vaccine effectiveness, SARS-CoV-2, COVID-19, negative control outcome, cohort analysis

4.

Observed Protection Against SARS-CoV-2 Reinfection Following a Primary Infection: A Danish Cohort Study Using Two Years of Nationwide PCR-Test Data

Number of pages: 22 Posted: 10 Mar 2022
Statens Serum Institut - Department of Bacteria, Parasites and Fungi, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Statens Serum Institut - Department of Data Management and Analysis, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Statens Serum Institut, University of Copenhagen - Rigshospitalet, Statens Serum Institut, Statens Serum Institut, Statens Serum Institut, Statens Serum Institut, Statens Serums Institut - Department of Infectious Disease Epidemiology and Statens Serum Institut - Infectious Disease Epidemiology & Prevention
Downloads 536 (98,791)
Citation 3

Abstract:

Loading...

COVID-19, Cohort Studies, Immunity, reinfection, herd immunity, SARS-CoV-2 variants, epidemic

5.

Relative Vaccine Protection, Disease Severity and Symptoms Associated with Infection with SARS-CoV-2 Omicron Subvariant Ba.2.86 and Descendent Jn.1: A Danish Nationwide Register-Based Study

Number of pages: 30 Posted: 08 Feb 2024
Statens Serum Institut, Statens Serum Institut - Department of Epidemiology Research, Statens Serum Institut, Statens Serum Institut, Statens Serum Institut, Statens Serum Institut - Department of Epidemiology Research, Statens Serum Institut - Department of Data Management and Analysis, Statens Serum Institut, Statens Serum Institut - Virus Research & Development Laboratory, Statens Serum Institut, Statens Serum Institut - Virus Research & Development Laboratory, Statens Serum Institut, Statens Serum Institut, Statens Serum Institut, Statens Serum Institut, Herlev Hospital, Southwest Jutland Hospital, Aarhus University - Department of Infectious Diseases, Vejle Hospital, Odense University Hospital, Odense University Hospital, University of Copenhagen - Hvidovre Hospital, Zealand University Hospital, Slagelse University Hospital, Aalborg University Hospital, University of Southern Denmark, Statens Serum Institut, Statens Serum Institut, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Statens Serum Institut - Virus Research & Development Laboratory and Statens Serum Institut - Infectious Disease Epidemiology & Prevention
Downloads 254 (225,940)
Citation 1

Abstract:

Loading...

COVID-19, variant, severity, vaccine effectiveness

6.

Global Serotype Distribution of Remaining Invasive Pneumococcal Disease after Extensive Use of Pcv10/13: The Pserenade Project

Number of pages: 59 Posted: 13 Mar 2024
Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins University - International Vaccine Access Center, Johns Hopkins University - Department of Epidemiology, Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins Bloomberg School of Public Health - Department of International Health, International Vaccine Access Center, World Health Organization (WHO) - Department of Immunizations, Vaccines and Biologicals, University of the Witwatersrand - Department of Clinical Microbiology and Infectious Diseases, RWTH Aachen University - RWTH University Hospital Aachen, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, Consejería de Sanidad - Servicio de Epidemiología, Yale University - Institute for Global Health, affiliation not provided to SSRN, Centers for Disease Control & Prevention - National Center for Immunization and Respiratory Diseases, Centre Hospitalier Intercommunal de Créteil, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, University of West Attica, National Institute of Public Health, affiliation not provided to SSRN, World Health Organization, Government of the United Kingdom - NHS Greater Glasgow and Clyde, London School of Hygiene & Tropical Medicine, Epiconcept, Riga Stradins University, University of Melbourne - Murdoch Children's Research Institute, World Health Organization (WHO), Toyama Institute of Health - Department of Bacteriology, Tampere University - Faculty of Social Sciences, INEI - ANLIS “Dr. Carlos G. Malbrán" - Servicio de Bacteriología Clínica, World Health Organization’s Regional Office for Africa, Hospital Sant Joan de Deu - Molecular Microbiology Department, Public Health Agency of Sweden, Australian Government - Centre for Disease Control, University of Toronto, Regional Authority of Public Health - National Reference Centre for Pneumococcal and Haemophilus Diseases, London School of Hygiene & Tropical Medicine - Medical Research Council Unit: The Gambia, LACEN - Laboratório Central de Saúde Pública, Public Health England - Immunisation and Countermeasures Division, Landspitali - The National University Hospital - Department of Clinical Microbiology, National Institute of Public Health, National Health Laboratory Services (NHLS) - Centre for Respiratory Diseases and Meningitis, Kaiser Permanente Northern California - Kaiser Permanente Vaccine Study Center, University of Calgary, University of Sydney, The University of Hong Kong - Department of Microbiology, University of Bern, Government of the United States of America - Arctic Investigations Program, Johns Hopkins Bloomberg School of Public Health - Department of International Health, International Vaccine Access Center, National Institute of Public Health, ESR (Institute of Environmental Science and Research) - Health Intelligence Team, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, University of Liverpool, Mohammed VI University of Health Sciences, KU Leuven - University Hospitals Leuven, Université Laval, Statens Serum Institut, Ben-Gurion University of the Negev - Faculty of Health Science, Children’s Health Ireland at Temple Street - Irish Meningitis and Sepsis Reference Laboratory, European Centre for Disease Prevention and Control, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, Instituto de Salud Pública y Laboral de Navarra, Italian National Institute of Health, National Centre for Infectious Diseases, University of Utah Health Sciences Center - Division of Pediatric Infectious Diseases, Instituto Adolfo Lutz, Instituto de Salud Pública de Chile, Johns Hopkins Bloomberg School of Public Health - Department of International Health, International Vaccine Access Center and Independent
Downloads 118 (449,352)

Abstract:

Loading...

IPD, PCV impact, global, serotype distribution, all ages

7.

SARS-CoV-2 Vaccine-Induced Antibodies Protect Against Omicron Breakthrough Infection

Number of pages: 20 Posted: 24 Feb 2023
Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aalborg University - Department of Infectious Diseases, Aalborg University - Department of Infectious Diseases, Aalborg University - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Zealand University Hospital - Department of Infectious Diseases, Zealand University Hospital - Department of Medicine, Zealand University Hospital - Department of Medicine, University of Copenhagen - Department of Infectious Diseases, University of Copenhagen - Department of Cardiology, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Department of Public Health, Aarhus University - Department of Clinical Immunology, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aarhus University - Department of Infectious Diseases and Aarhus University - Department of Infectious Diseases
Downloads 86 (543,360)

Abstract:

Loading...

SARS-CoV-2, Omicron, COVID-19, Breakthrough Infection, Antibodies, Vaccination, Seroconversion, Case-Control

8.

Global Impact of 10- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in All Ages: The PSERENADE Project

Number of pages: 36 Posted: 19 Mar 2024
Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins Bloomberg School of Public Health - Department of International Health, International Vaccine Access Center, University of Oxford - KEMRI-Coast Centre for Geographical Medicine and Research, Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins University - Department of Epidemiology, Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins University - Bloomberg School of Public Health, University of Massachusetts Worcester - UMass Chan Medical School, Johns Hopkins University - Bloomberg School of Public Health, World Health Organization (WHO) - Department of Immunizations, Vaccines and Biologicals, Yale University - Institute for Global Health, OsloMet - Oslo Metropolitan University - Faculty of Health Sciences, University of the Witwatersrand - Department of Clinical Microbiology and Infectious Diseases, Santé Publique France, RWTH Aachen University - RWTH University Hospital Aachen, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Mie National Hospital, National Institute for Public Health and Environment, National Medicines Institute, National Institute of Public Health, London School of Hygiene & Tropical Medicine, Epiconcept, Riga Stradins University, Rey Juan Carlos University, University of Melbourne - Murdoch Children's Research Institute, University of Calgary, Institute of Public Health of Chile - National Agency for Medical Devices, Innovation and Development (ANDID), Tampere University - Faculty of Social Sciences, Health Protection Surveillance Centre (HPSC), Australian Government - Centre for Disease Control, University of Toronto, Regional Authority of Public Health - National Reference Centre for Pneumococcal and Haemophilus Diseases, London School of Hygiene & Tropical Medicine - Medical Research Council Unit: The Gambia, Government of the United Kingdom - Public Health Scotland, Public Health Agency of Sweden, Public Health England - Immunisation and Countermeasures Division, Landspitali - The National University Hospital - Department of Clinical Microbiology, National Institute of Public Health, Kaiser Permanente Northern California - Kaiser Permanente Vaccine Study Center, University of Sydney, The University of Hong Kong - Department of Microbiology, University of Bern, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Child Health Research Foundation, Johns Hopkins Bloomberg School of Public Health - Department of International Health, International Vaccine Access Center, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), National Institute of Public Health, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, National Public Health Organization, Athens, affiliation not provided to SSRN, Mohammed VI University of Health Sciences, KU Leuven - University Hospitals Leuven, Université Laval, Ben-Gurion University of the Negev - Faculty of Health Science, European Centre for Disease Prevention and Control, National Health Laboratory Services (NHLS) - Centre for Respiratory Diseases and Meningitis, Generalitat de Catalunya, Ministry of Health, Kenya Medical Research Institute (KEMRI), Italian National Institute of Health, Government of the United States of America - National Center for Emerging and Zoonotic Infectious Diseases, Instituto Adolfo Lutz, Kenya Medical Research Institute (KEMRI), University of Utah Health Sciences Center - Division of Pediatric Infectious Diseases, Johns Hopkins Bloomberg School of Public Health - Department of International Health, International Vaccine Access Center, Johns Hopkins University - International Vaccine Access Center and Independent
Downloads 81 (571,748)
Citation 1

Abstract:

Loading...

invasive pneumococcal disease, pneumococcal conjugate vaccines, serotypes, vaccine impact, incidence, serotype replacement, indirect protection